Medarex greenshoe exercised, raising public stock offering to 11.5 million shares

By Lisa Kerner

Erie, Pa., May 8 - Medarex, Inc. said the underwriters of its public stock offering exercised the 1.5 million share over-allotment in full, raising the size of the deal to 11.5 million shares or $135 million.

Medarex originally priced 10 million shares on April 6 at $11.75 per share.

Goldman, Sachs & Co. was the bookrunner for the deal, while J.P. Morgan Securities Inc. was the joint lead manager, and Janney Montgomery Scott LLC served as a co-manager.

Princeton, N.J.-based Medarex is focused on human antibody-based therapeutic products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.